- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 2.08 Å
- Oligo State
- homo-dimer
- Ligands
- 8 x NAG- NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
- 2 x NAG- NAG- BMA- MAN- MAN: alpha-D-mannopyranose-(1-3)-[alpha-D-mannopyranose-(1-6)]beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose
NAG-NAG-BMA-MAN-MAN.5: 10 residues within 4Å:- Chain A: S.620, S.623, A.624, N.627, Q.729
- Chain B: L.99, H.101, E.265, Y.266, R.343
1 PLIP interactions:1 interactions with chain B- Hydrogen bonds: B:R.343, B:R.343
- Water bridges: B:L.99
NAG-NAG-BMA-MAN-MAN.17: 10 residues within 4Å:- Chain A: L.99, H.101, E.265, Y.266, R.343
- Chain B: S.620, S.623, A.624, N.627, Q.729
1 PLIP interactions:1 interactions with chain A- Hydrogen bonds: A:R.343, A:R.343
- Water bridges: A:L.99
- 4 x NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
NAG.6: 2 residues within 4Å:- Chain A: N.184, S.186
2 PLIP interactions:2 interactions with chain A- Hydrogen bonds: A:N.184, A:S.186
NAG.7: 4 residues within 4Å:- Chain A: W.235, N.448, F.554, Y.555
5 PLIP interactions:5 interactions with chain A- Hydrophobic interactions: A:W.235, A:Y.555
- Hydrogen bonds: A:W.235, A:F.554
- Water bridges: A:N.448
NAG.18: 2 residues within 4Å:- Chain B: N.184, S.186
2 PLIP interactions:2 interactions with chain B- Hydrogen bonds: B:N.184, B:S.186
NAG.19: 4 residues within 4Å:- Chain B: W.235, N.448, F.554, Y.555
5 PLIP interactions:5 interactions with chain B- Hydrophobic interactions: B:W.235, B:Y.555
- Hydrogen bonds: B:W.235, B:F.554
- Water bridges: B:N.448
- 4 x ZN: ZINC ION(Non-covalent)
ZN.8: 6 residues within 4Å:- Chain A: H.366, D.376, E.413, E.414, D.442
- Ligands: ZN.9
5 PLIP interactions:4 interactions with chain A, 1 Ligand-Water interactions- Metal complexes: A:H.366, A:D.376, A:D.442, A:D.442, H2O.8
ZN.9: 5 residues within 4Å:- Chain A: D.376, E.414, H.542
- Ligands: ZN.8, J37.12
5 PLIP interactions:4 interactions with chain A, 1 Ligand-Water interactions- Metal complexes: A:D.376, A:E.414, A:E.414, A:H.542, H2O.8
ZN.20: 6 residues within 4Å:- Chain B: H.366, D.376, E.413, E.414, D.442
- Ligands: ZN.21
5 PLIP interactions:4 interactions with chain B, 1 Ligand-Water interactions- Metal complexes: B:H.366, B:D.376, B:D.442, B:D.442, H2O.27
ZN.21: 5 residues within 4Å:- Chain B: D.376, E.414, H.542
- Ligands: ZN.20, J37.24
5 PLIP interactions:4 interactions with chain B, 1 Ligand-Water interactions- Metal complexes: B:D.376, B:E.414, B:E.414, B:H.542, H2O.27
- 2 x CL: CHLORIDE ION(Non-functional Binders)
- 2 x CA: CALCIUM ION(Non-covalent)
CA.11: 4 residues within 4Å:- Chain A: T.258, Y.261, E.422, E.425
5 PLIP interactions:4 interactions with chain A, 1 Ligand-Water interactions- Metal complexes: A:T.258, A:E.422, A:E.422, A:E.425, H2O.1
CA.23: 4 residues within 4Å:- Chain B: T.258, Y.261, E.422, E.425
5 PLIP interactions:4 interactions with chain B, 1 Ligand-Water interactions- Metal complexes: B:T.258, B:E.422, B:E.422, B:E.425, H2O.19
- 2 x J37: N-({(1S)-6-(4-bromobenzyl)-1-carboxy-7,47-dioxo-52-[(3aS,4S,6aR)-2-oxohexahydro-1H-thieno[3,4-d]imidazol-4-yl]-10,13,16,19,22,25,28,31,34,37,40,43-dodecaoxa-6,46-diazadopentacont-1-yl}carbamoyl)-L-glutamic acid(Non-covalent)
J37.12: 20 residues within 4Å:- Chain A: F.198, R.199, N.246, D.376, E.413, E.414, G.416, L.417, E.446, R.452, D.454, G.507, N.508, R.523, R.525, Y.541, H.542, K.688, Y.689
- Ligands: ZN.9
26 PLIP interactions:26 interactions with chain A- Hydrophobic interactions: A:L.417, A:Y.541
- Hydrogen bonds: A:N.246, A:N.246, A:E.414, A:R.452, A:R.452, A:G.507, A:G.507, A:G.507, A:G.507, A:N.508, A:Y.541, A:Y.689
- Water bridges: A:N.246, A:E.446, A:R.523, A:R.525, A:K.688
- Salt bridges: A:R.199, A:R.523, A:R.525, A:H.542, A:K.688
- pi-Cation interactions: A:R.452, A:R.523
J37.24: 20 residues within 4Å:- Chain B: F.198, R.199, N.246, D.376, E.413, E.414, G.416, L.417, E.446, R.452, D.454, G.507, N.508, R.523, R.525, Y.541, H.542, K.688, Y.689
- Ligands: ZN.21
26 PLIP interactions:26 interactions with chain B- Hydrophobic interactions: B:L.417, B:Y.541
- Hydrogen bonds: B:N.246, B:N.246, B:E.414, B:R.452, B:R.452, B:G.507, B:G.507, B:G.507, B:G.507, B:N.508, B:Y.541, B:Y.689
- Water bridges: B:N.246, B:E.446, B:R.523, B:R.525, B:K.688
- Salt bridges: B:R.199, B:R.523, B:R.525, B:H.542, B:K.688
- pi-Cation interactions: B:R.452, B:R.523
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Tykvart, J. et al., Rational design of urea-based glutamate carboxypeptidase II (GCPII) inhibitors as versatile tools for specific drug targeting and delivery. Bioorg.Med.Chem. (2014)
- Release Date
- 2014-06-18
- Peptides
- Glutamate carboxypeptidase 2: AB
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AB
A
- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 2.08 Å
- Oligo State
- homo-dimer
- Ligands
- 8 x NAG- NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
- 2 x NAG- NAG- BMA- MAN- MAN: alpha-D-mannopyranose-(1-3)-[alpha-D-mannopyranose-(1-6)]beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose
- 4 x NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
- 4 x ZN: ZINC ION(Non-covalent)
- 2 x CL: CHLORIDE ION(Non-functional Binders)
- 2 x CA: CALCIUM ION(Non-covalent)
- 2 x J37: N-({(1S)-6-(4-bromobenzyl)-1-carboxy-7,47-dioxo-52-[(3aS,4S,6aR)-2-oxohexahydro-1H-thieno[3,4-d]imidazol-4-yl]-10,13,16,19,22,25,28,31,34,37,40,43-dodecaoxa-6,46-diazadopentacont-1-yl}carbamoyl)-L-glutamic acid(Non-covalent)
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Tykvart, J. et al., Rational design of urea-based glutamate carboxypeptidase II (GCPII) inhibitors as versatile tools for specific drug targeting and delivery. Bioorg.Med.Chem. (2014)
- Release Date
- 2014-06-18
- Peptides
- Glutamate carboxypeptidase 2: AB
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AB
A